Table 2.
Baseline Characteristics of the diabetic and non-diabetic Chronic Kidney Disease (CKD) populations studied.
| Diabetic Patients | Non-Diabetic Patients | p (Diab-Non-Diab) | |
|---|---|---|---|
| N | 149 | 300 | - |
| (33.18%) | (66.82%) | ||
| Males (%) | 87 | 190 | 0.315 |
| (58.39%) | (63.33%) | ||
| BMI | 27.14 | 25.71 | 0.07 |
| median (min–max) | (15.5–44.92) | (13.32–46.67) | |
| IQR | 4.8 | 4.79 | |
| Age | 70 | 70 | 0.467 |
| median (min–max) | (19–92) | (23–97) | |
| IQR | 13 | 22.5 | |
| Age over 65 (%) | 78 | 118 | 0.006 |
| (52.35%) | (39.33%) | ||
| Age over 80 (%) | 23 | 66 | 0.141 |
| (15.44%) | (22.00%) | ||
| Charlson | 8 | 6 | 0.002 |
| median (min–max) | (2–13) | (2–13) | |
| IQR | 3 | 4 | |
| Charlson ≥ 7 (%) | 122 | 124 | <0.001 |
| (81.88%) | (41.33%) | ||
| Charlson ≥ 10 (%) | 44 | 27 | <0.001 |
| (29.53%) | (9.00%) | ||
| Cardiopathy (%) | 63 | 145 | 0.171 |
| (42.28%) | (48.33%) | ||
| sCreatinine (mg/dL) | 2.78 | 2.8 | 0.436 |
| median (min–max) | (0.90–6.80) | (0.55–16) | |
| IQR | 1.47 | 1.88 | |
| eGFR-EPI (mL/min) | 20 | 20 | 0.797 |
| median (min–max) | (6.3–79.7) | (3–127.10) | |
| IQR | 11.2 | 15.9 | |
| GFR < 15 mL/min at enrolment n (%) | 35 | 90 | 0.147 |
| (23.49%) | (30.00%) | ||
| GFR < 10 mL/min at enrolment n (%) | 13 | 31 | 0.589 |
| (8.72%) | (10.33%) | ||
| Proteinuria (g/day) | 0.8 | 0.7 | 0.553 |
| median (min–max) | (0.08–15.80) | (0.04–11) | |
| IQR | 2.95 | 1.7 | |
| Proteinuria ≥ 1 g/day (%) | 78 | 124 | 0.027 |
| (52.35%) | (41.33%) | ||
| Proteinuria ≥ 3 g/day (%) | 41 | 41 | 0.002 |
| (27.52%) | (13.67%) |
Legend: Charlson: Charlson’s comorbidity index; E-GFR EPI: Glomerular Filtration Rate (GFR) according to the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation: Diab: Diabetes; IQR: Interquartile range; BMI: Body Mass Index.